BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38426361)

  • 21. Cytopathology of extra-renal perivascular epithelioid cell tumor (PEComa): a series of 7 cases and review of the literature.
    Wangsiricharoen S; Larman TC; Wakely PE; Siddiqui MT; Ali SZ
    J Am Soc Cytopathol; 2021; 10(2):175-186. PubMed ID: 33162379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Malignant perivascular epithelioid cell tumor (PEComa) of the uterus.
    Cao B; Huang Y
    BMC Womens Health; 2022 Dec; 22(1):523. PubMed ID: 36522714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single-center Experience in the Diagnosis and Treatment of Hepatic Perivascular Epithelioid Cell Neoplasm.
    Jia J; Luo J; Pan CG; Ge G; Feng M; Zou B; Liu L; Zheng S; Yu J
    J Clin Transl Hepatol; 2022 Feb; 10(1):72-79. PubMed ID: 35233375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case of caecal "PECOMA": An uncommon entity.
    Razak O A; Varela C; Nassr MMA; Jang M; Han YD
    Int J Surg Case Rep; 2022 Jan; 90():106689. PubMed ID: 34974354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perivascular epitheliod cell tumors: Study of three gynecological cases.
    Nicolás I; Fusté P; Saco A; Ordi J; Torné A
    Med Clin (Barc); 2019 Jul; 153(2):83-87. PubMed ID: 30827678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A huge malignant perivascular epithelioid cell tumor (PEComa) of the uterine cervix and vagina.
    Natella V; Merolla F; Giampaolino P; Bifulco G; Mainenti PP; Insabato L
    Pathol Res Pract; 2014 Mar; 210(3):186-8. PubMed ID: 24331571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perivascular epithelioid cell neoplasm (PEComa) of the gynecologic tract: clinicopathologic and immunohistochemical characterization of 16 cases.
    Schoolmeester JK; Howitt BE; Hirsch MS; Dal Cin P; Quade BJ; Nucci MR
    Am J Surg Pathol; 2014 Feb; 38(2):176-88. PubMed ID: 24418852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PNL2: A Useful Adjunct Biomarker to HMB45 in the Diagnosis of Uterine Perivascular Epithelioid Cell Tumor (PEComa).
    Valencia-Guerrero A; Pinto A; Anderson WJ; Trevisan G; Nucci MR; Hirsch MS
    Int J Gynecol Pathol; 2020 Nov; 39(6):529-536. PubMed ID: 31851063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uterine perivascular epithelioid cell neoplasms (PEComas): report of two cases and literature review.
    Cossu A; Paliogiannis P; Tanda F; Dessole S; Palmieri G; Capobianco G
    Eur J Gynaecol Oncol; 2014; 35(3):309-12. PubMed ID: 24984548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TFE3 Gene Rearrangement in Perivascular Epithelioid Cell Neoplasm (PEComa) of the Genitourinary Tract.
    Vannucchi M; Minervini A; Salvi M; Montironi R; Raspollini MR
    Clin Genitourin Cancer; 2020 Dec; 18(6):e692-e697. PubMed ID: 32576448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transurethral en bloc resection of a bladder perivascular epithelioid cell tumor (PEComa): a case report.
    Zeng SP; Sun YF; Ye JB; Zeng K; Li XB
    BMC Urol; 2023 Mar; 23(1):28. PubMed ID: 36864398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid and Durable Response With Nab-Sirolimus After Everolimus Failure in a Patient With Perivascular Epithelioid Cell Tumors (PEComas) of the Uterus.
    Kopparthy P; Murphy M
    Cureus; 2021 May; 13(5):e14951. PubMed ID: 34123648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary Cutaneous Malignant Perivascular Epithelioïd Cell Tumor (PEComa): Case Report With Review of the Literature.
    Elousrouti LT; Mouaddine A; Fadlallah I; Elhitmy S; Elloudi S; Mernissi F; Elidrissi M; Hammas N; Elfatemi H; Chbani L
    Clin Pathol; 2023; 16():2632010X231178629. PubMed ID: 37360521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Malignant Perivascular Epithelioid Cell Tumor (PEComa) of the Uterus as Part of the Hereditary Cancer Syndrome: A Case Diagnosed with Multiple Malignancies.
    Caliskan S; Akar OS; Gun S; Kefeli M
    Turk Patoloji Derg; 2023; 39(3):212-217. PubMed ID: 36367123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. VEGFR Inhibitors for Uterine Metastatic Perivascular Epithelioid Tumors (PEComa) Resistant to mTOR Inhibitors. A Case Report and Review of Literature.
    Liapi A; Mathevet P; Herrera FG; Hastir D; Sarivalasis A
    Front Oncol; 2021; 11():641376. PubMed ID: 33842348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two cases of perivascular epithelioid cell tumor of the uterus: clinical, radiological and pathological diagnostic challenge.
    Kwon BS; Suh DS; Lee NK; Song YJ; Choi KU; Kim KH
    Eur J Med Res; 2017 Mar; 22(1):7. PubMed ID: 28270196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TFE3-associated perivascular epithelioid cell tumor with complete response to mTOR inhibitor therapy: report of first case and literature review.
    Purwar R; Soni K; Shukla M; Verma A; Kumar T; Pandey M
    World J Surg Oncol; 2022 Mar; 20(1):62. PubMed ID: 35232443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Update on the imaging of malignant perivascular epithelioid cell tumors (PEComas).
    Phillips CH; Keraliya AR; Shinagare AB; Ramaiya NH; Tirumani SH
    Abdom Radiol (NY); 2016 Feb; 41(2):368-76. PubMed ID: 26867923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Laparoscopic radical nephroureterectomy in the oblique supine lithotomy integrative position for rare renal malignant perivascular epithelioid cell tumor with renal vein cancerous thrombosis: A case report and literature review.
    Lin C; Liang S; Wang Y; Liang A; Qin W; Huang J; Meng H; Liu H; Chen M; Meng L
    Medicine (Baltimore); 2022 Sep; 101(38):e30653. PubMed ID: 36197208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Perivascular epithelioid cell tumor, not otherwise specified: a clinicopathologic and immunohistochemical analysis of 31 cases].
    Cai JN; Shi M; Wang J
    Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):240-5. PubMed ID: 21615997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.